Medicines with active substance Tapentadol phosphate – Spain
Filters
Clear filtersFilters
P
Pagrentil retard 100 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 153.13 mg
Active substance: Tapentadol phosphate
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required
Pagrentil retard 150 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 229.70 mg
Active substance: Tapentadol phosphate
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required
Pagrentil retard 200 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 306.27 mg
Active substance: Tapentadol phosphate
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required
Pagrentil retard 25 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 38.28 mg
Active substance: Tapentadol phosphate
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required
Pagrentil retard 250 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 382.84 mg
Active substance: Tapentadol phosphate
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required
Pagrentil retard 50 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 76.57 mg
Active substance: Tapentadol phosphate
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required
Palgesic retard 100 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 153.13 mg
Active substance: Tapentadol phosphate
Manufacturer: Kern Pharma S.L.
Prescription required
Palgesic retard 150 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 229.70 mg
Active substance: Tapentadol phosphate
Manufacturer: Kern Pharma S.L.
Prescription required
Palgesic retard 200 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 306.27 mg
Active substance: Tapentadol phosphate
Manufacturer: Kern Pharma S.L.
Prescription required
Palgesic retard 25 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 38.28 mg
Active substance: Tapentadol phosphate
Manufacturer: Kern Pharma S.L.
Prescription required
Palgesic retard 250 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 382.84 mg
Active substance: Tapentadol phosphate
Manufacturer: Kern Pharma S.L.
Prescription required
Palgesic retard 50 mg comprimidos de liberaciÓn prolongada efg
Dosage form: Prolonged‑release tablet, 76.57 mg
Active substance: Tapentadol phosphate
Manufacturer: Kern Pharma S.L.
Prescription required
Stay informed and save on care
Get health tips, platform updates, and exclusive promos for subscribers.
Follow us on social media
